Home > Insider Trading > Filing (0001437749-13-008386)

Filing Details

Accession Number:: 0001437749-13-008386
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-07-02 17:47:23
Reporting Period:: 2013-06-28

Filing Date:: 2013-07-02
Accepted Time:: 2013-07-02 17:47:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1484478	Furiex Pharmaceuticals Inc.	FURX	Pharmaceutical Preparations (2834)	271197863

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1176312	B Peter Corr	C/O Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150 Morrisville NC 27560		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-06-28	385	$34.03	6,508	No	4	S	Direct
Common Stock	Disposition	2013-06-28	2,913	$0.00	3,595	No	5	G	Direct
Common Stock	Disposition	2013-07-01	15	$0.00	3,580	No	5	G	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	5	G	Direct
No	5	G	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (to buy)	$9.11	2020-06-17	12,970	12,970	Direct
Common Stock	Stock Options (to buy)	$13.94	2021-05-19	8,675	8,675	Direct
Common Stock	Stock Options (to buy)	$13.45	2021-10-12	8,825	8,825	Direct
Common Stock	Stock Options (to buy)	$18.22	2022-05-24	17,500	17,500	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2020-06-17	12,970	12,970	Direct
2021-05-19	8,675	8,675	Direct
2021-10-12	8,825	8,825	Direct
2022-05-24	17,500	17,500	Direct

Footnotes

Represents shares sold to pay the exercise price of stock options exercised in order to make a charitable donation.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.99 to $34.17, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.